What does CUSIP 004225108 represent in this 13F holders report?

CUSIP 004225108 is the security identifier for ACAD - ACADIA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in Q2 2023?

232 institutional investors reported ACAD - ACADIA PHARMACEUTICALS INC - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)

CUSIP: 004225108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 170,504,990
Total 13F shares: 159,054,444
Share change: +1,137,650
Total reported value: $3,809,481,545
Put/Call ratio: 80%
Price per share: $23.95
Number of holders: 232
Value change: +$45,597,747
Number of buys: 108
Number of sells: 105

Quarterly Holders Quick Answers

What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 004225108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	25%	41,938,486	$789,282,307	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	8%	13,678,809	$257,435,185	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	5.8%	9,869,131	$185,737,046	—	31 Mar 2023	13F
RTW INVESTMENTS, LP	13F	Company	4.8%	8,242,864	$155,130,700	—	31 Mar 2023	13F
FMR LLC	13F	Company	4.6%	7,846,673	$147,674,386	—	31 Mar 2023	13F
EcoR1 Capital, LLC	13F	Company	3.5%	5,991,479	$112,759,635	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	3.3%	5,586,861	$105,144,724	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	2.9%	4,900,582	$92,228,953	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.7%	4,550,906	$85,649,000	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	2.3%	3,914,704	$73,674,730	—	31 Mar 2023	13F
FIRST TRUST ADVISORS LP	13F	Company	1.6%	2,714,485	$51,086,607	—	31 Mar 2023	13F
Palo Alto Investors LP	13F	Company	1.4%	2,405,793	$45,277,024	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	2,390,267	$44,984,844	—	31 Mar 2023	13F
NORGES BANK	13F	Company	1.2%	2,021,913	$38,052,403	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.1%	1,882,353	$35,425,883	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1%	1,752,013	$32,973,000	—	31 Mar 2023	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	1%	1,725,626	$32,476,282	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.93%	1,584,784	$29,825,764	—	31 Mar 2023	13F
EMERALD ADVISERS, LLC	13F	Company	0.88%	1,496,560	$28,165,259	—	31 Mar 2023	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.8%	1,367,601	$25,710,899	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.72%	1,225,000	$23,054,500	—	31 Mar 2023	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.71%	1,207,302	$22,721,424	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.69%	1,180,637	$22,219,587	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.68%	1,166,724	$21,957,745	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.57%	979,738	$18,438,669	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.57%	969,294	$18,242,113	—	31 Mar 2023	13F
Finepoint Capital LP	13F	Company	0.54%	916,353	$17,245,763	—	31 Mar 2023	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.52%	887,126	$16,695,711	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.52%	882,275	$16,604,416	—	31 Mar 2023	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.51%	872,050	$16,411,981	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.5%	857,338	$16,135,101	—	31 Mar 2023	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.43%	728,001	$13,700,979	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.39%	661,639	$12,452,045	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	0.39%	659,506	$12,411,906	—	31 Mar 2023	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.35%	596,300	$11,222,366	—	31 Mar 2023	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.34%	581,314	$11,027,527	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.34%	580,475	$10,924,539	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.34%	572,170	$10,768,244	—	31 Mar 2023	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.31%	534,055	$10,050,915	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.31%	521,249	$9,810,000	—	31 Mar 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.29%	498,178	$9,375,710	—	31 Mar 2023	13F
Rockefeller Capital Management L.P.	13F	Company	0.28%	480,880	$9,049,000	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.28%	473,970	$8,920,115	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.27%	454,528	$8,554,216	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.25%	430,905	$8,109,632	—	31 Mar 2023	13F
Walleye Capital LLC	13F	Company	0.25%	418,843	$7,882,625	—	31 Mar 2023	13F
NOMURA HOLDINGS INC	13F	Company	0.21%	365,662	$6,881,759	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.19%	332,361	$6,255,034	—	31 Mar 2023	13F
Russell Investments Group, Ltd.	13F	Company	0.19%	324,810	$6,112,922	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.16%	278,528	$5,241,897	—	31 Mar 2023	13F

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q2 2023

As of 30 Jun 2023, ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by 232 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 159,054,444 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Inc., RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, EcoR1 Capital, LLC, STATE STREET CORP, FMR LLC, D. E. Shaw & Co., Inc., and MORGAN STANLEY. This page lists 232 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

231

Q2 2023 holders

232

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.